Diagnosing Cushing's syndrome
Perry and Grossman I in their comprehensive and excellent review pointed out that Cushing's syndrome remains one of the most difficult diagnostic problems in endocrinology. We wish to refer to a case of Cushing's syndrome? in which the hyperplastic nodular adrenals produced a large amount of unusual C2l-steroids, including 2l-deoxycortisol. Excessive production of this steroid appeared to have played an aetiological role by interfering with the feedback inhibition of cortisol on hypothalamic receptors controlling adrenocorticotrophic hormone (ACTH) release leading to enhanced ACTH production and perpetuating the hypercortisolaemic state. The affinity of 21-deoxycortisol for transcortin is known to be approximately 80% that of cortisol itself. From the study of the effects of molecular structure on the ability to promote or inhibit ACTH release, it seems that a C21 compound lacking the 21-hydroxyl function could inhibit the suppression of ACTH by cortisol. This mechanism has been proposed to explain the apparent difficulty in regulating ACTH levels in congenital adrenal hyperplasia due to 21hydroxylase deficiency, a disorder obviously associated with synthesis of excessive amounts of 2l-deoxy C21-compounds. We postulated that 21-deoxycortisol and related compounds competed for receptors involved in ACTH regulation in a manner analogous to the interaction of clomiphene with oestrogen receptors enhancing gonadotrophin secretion, or the antiglucocortoid steroid analogue RU486, resulting in ACTH release and the stimulation of adrenocortical activity and cortisol production. Although the Cushing's case we described was the first in whom excessive production of 21deoxycortisol metabolites attracted our attention, it is probably not unique. It appears that
